The Global Oncology Radiopharmaceuticals Market Propelled By Increased Use Of Radiopharmaceuticals In Cancer Diagnosis And Treatment
by The global oncology radiopharmaceuticals market is estimated to be valued at US$ 7351 Mn in 2023 and is expected to exhibit a CAGR of 3.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.